Empower Advisory Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.8M Buy
139,154
+314
+0.2% +$27.5K 0.03% 163
2026
Q1
$11.8M Sell
138,840
-24,364
-15% -$2.17M 0.03% 155
2025
Q4
$12.9M Buy
163,204
+18,435
+13% +$1.45M 0.03% 157
2025
Q3
$11.6M Sell
144,769
-18,238
-11% -$1.56M 0.03% 160
2025
Q2
$14.8M Buy
163,007
+1,089
+0.7% +$99.4K 0.04% 146
2025
Q1
$15.2M Sell
161,918
-1,391
-0.9% -$125K 0.05% 141
2024
Q4
$14.8M Sell
163,309
-10,489
-6% -$1M 0.05% 144
2024
Q3
$18M Buy
173,798
+8,047
+5% +$820K 0.06% 133
2024
Q2
$16.1M Sell
165,751
-4,651
-3% -$429K 0.06% 136
2024
Q1
$15.3M Sell
170,402
-5,206
-3% -$441K 0.06% 138
2023
Q4
$14M Sell
175,608
-7,600
-4% -$571K 0.06% 147
2023
Q3
$13M Buy
183,208
+857
+0.5% +$64.1K 0.06% 140
2023
Q2
$14M Buy
182,351
+170
+0.1% +$13.2K 0.06% 146
2023
Q1
$13.7M Buy
+182,181
New +$13.5M 0.06% 144

Other funds holding CL

Empower Advisory Group's CL Position: Q2 2026 in Review

Empower Advisory Group increased its Colgate-Palmolive (CL) stake by 0.23% in Q2 2026, buying an estimated $27.5K and bringing the position to 139,154 shares worth $12.8M. The position accounts for 0.03% of the portfolio, ranked #163.

Empower Advisory Group first reported a position in CL in Q1 2023 and has held it in 14 quarters since. The position peaked at $18M in Q3 2024. 2,020 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Empower Advisory Group held 139,154 shares of Colgate-Palmolive worth $12.8M as of Q2 2026.
  • Empower Advisory Group bought 314 Colgate-Palmolive shares in Q2 2026, an estimated $27.5K.
  • Colgate-Palmolive made up 0.03% of Empower Advisory Group's portfolio in Q2 2026, its #163 holding.
  • Empower Advisory Group first reported a position in Colgate-Palmolive in Q1 2023 and has held it in 14 quarters since.
  • Empower Advisory Group's Colgate-Palmolive position peaked at $18M in Q3 2024.
  • 2,020 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Empower Advisory Group's 13F filing for Q2 2026, filed 12 Aug 2026.